Table 4

FEV₁ ^4-150 response after 3 and 6 months of budesonide or placebo

Study period (months)		FEV₁ change^4-151(ml)		Treatment difference^4-151 Budesonide-placebo (ml)		No. (%) of patients with ⩾15% in change in FEV₁
Study period (months)		Budesonide	Placebo	Treatment difference^4-151 Budesonide-placebo (ml)		Budesonide	Placebo
0–3	n = 38	n = 34		n = 38	n = 34
	−13 (−59 to 33)	−1 (−65 to 62)	−12 (−88 to 63)	4 (11)	7 (20)
0–6	n = 36	n = 30		n = 36	n = 30
	8 (−51 to 68)	12 (−61 to 85)	−4 (−95 to 87)	6 (17)	8 (27)

↵4-150 Values are pre-bronchodilator FEV₁ responses.
↵4-151 Values are the means with 95% CI in parentheses for FEV₁change from baseline and treatment difference.